Choi S, Kim BK, Yon DK, et al. Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990–2019: A DALY-based analysis of the Global Burden of Disease 2019 study. Clin Mol Hepatol. 2023;29(2):433. https://doi.org/10.3350/CMH.2022.0316

Article  PubMed  PubMed Central  Google Scholar 

Kang SH, Lee HW, Yoo JJ, et al. KASL clinical practice guidelines: management of nonalcoholic fatty liver disease. Clin Mol Hepatol. 2021;27(3):363. https://doi.org/10.3350/CMH.2021.0178

Article  PubMed  PubMed Central  Google Scholar 

Lee HW, Kim M, Youn J, Singh S, Ahn SH. Liver diseases in south korea: a pulse check of the public’s knowledge, awareness, and behaviors. Yonsei Med J. 2022;63(12):1088–1098. https://doi.org/10.3349/YMJ.2022.0332

Article  PubMed  PubMed Central  Google Scholar 

Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020;73(1):202–209. https://doi.org/10.1016/J.JHEP.2020.03.039

Article  PubMed  Google Scholar 

Lin S, Huang J, Wang M, et al. Comparison of MAFLD and NAFLD diagnostic criteria in real world. Liver Int. 2020;40(9):2082–2089. https://doi.org/10.1111/LIV.14548

Article  PubMed  Google Scholar 

Ayada I, van Kleef LA, Alferink LJM, Li P, de Knegt RJ, Pan Q. Systematically comparing epidemiological and clinical features of MAFLD and NAFLD by meta-analysis: Focusing on the non-overlap groups. Liver Int. 2022;42(2):277–287. https://doi.org/10.1111/LIV.15139

Article  PubMed  Google Scholar 

Sohn W, Lee HW, Lee S, et al. Obesity and the risk of primary liver cancer: a systematic review and meta-analysis. Clin Mol Hepatol. 2021;27(1):157–174. https://doi.org/10.3350/CMH.2020.0176

Article  PubMed  Google Scholar 

Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2021;18(4):223–238. https://doi.org/10.1038/S41575-020-00381-6

Article  PubMed  Google Scholar 

Simon TG, Roelstraete B, Sharma R, Khalili H, Hagström H, Ludvigsson JF. Cancer risk in patients with biopsy-confirmed nonalcoholic fatty liver disease: a population-based cohort study. Hepatology. 2021;74(5):2410–2423. https://doi.org/10.1002/HEP.31845

Article  CAS  PubMed  Google Scholar 

Estes C, Anstee QM, Arias-Loste MT, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030. J Hepatol. 2018;69(4):896–904. https://doi.org/10.1016/J.JHEP.2018.05.036

Article  PubMed  Google Scholar 

Chan KE, Koh TJL, Tang ASP, et al. Global prevalence and clinical characteristics of metabolic-associated fatty liver disease: a meta-analysis and systematic review of 10 739 607 individuals. J Clin Endocrinol Metab. 2022;107(9):2691–2700. https://doi.org/10.1210/CLINEM/DGAC321

Article  PubMed  Google Scholar 

Liu J, Ayada I, Zhang X, et al. Estimating global prevalence of metabolic dysfunction-associated fatty liver disease in overweight or obese adults. Clin Gastroenterol Hepatol. 2022;20(3):e573–e582. https://doi.org/10.1016/J.CGH.2021.02.030

Article  PubMed  Google Scholar 

World Obesity Atlas 2023 | World Obesity Federation. Accessed December 17, 2023. https://www.worldobesity.org/resources/resource-library/world-obesity-atlas-2023

Vitale A, Svegliati-Baroni G, Ortolani A, et al. Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITALICA database. Gut. 2023. https://doi.org/10.1136/gutjnl-2021-324915

Article  PubMed  Google Scholar 

Myers S, Neyroud-Caspar I, Spahr L, et al. NAFLD and MAFLD as emerging causes of HCC: a populational study. JHEP Rep. 2021. https://doi.org/10.1016/J.JHEPR.2021.100231

Article  PubMed  PubMed Central  Google Scholar 

Yeoh A, Yang Z, Cheung R, Do A, Ahmed A, Wong RJ. Incidence of cirrhosis and hepatocellular carcinoma among veterans with noncirrhotic metabolic dysfunction-associated fatty liver disease. J Clin Gastroenterol. 2023. https://doi.org/10.1097/MCG.0000000000001921

Article  Google Scholar 

Song BG, Choi SC, Goh MJ, et al. Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma. JHEP Rep. 2023. https://doi.org/10.1016/J.JHEPR.2023.100810

Article  PubMed  PubMed Central  Google Scholar 

Stine JG, Wentworth BJ, Zimmet A, et al. Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases. Aliment Pharmacol Ther. 2018;48(7):696–703. https://doi.org/10.1111/APT.14937

Article  PubMed  PubMed Central  Google Scholar 

Vanlerberghe BTK, van Malenstein H, Sainz-Bariga M, et al. Utility and prognostic value of diagnosing MAFLD in patients undergoing liver transplantation for alcohol-related liver disease. Clin Transplant. 2023. https://doi.org/10.1111/CTR.14965

Article  PubMed  Google Scholar 

Turati F, Galeone C, Rota M, et al. Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies. Ann Oncol. 2014;25(8):1526–1535. https://doi.org/10.1093/ANNONC/MDU020

Article  CAS  PubMed  Google Scholar 

Xue J, Wang QX, Xiao HM, et al. Impact of metabolic dysfunction associated fatty liver disease on the prognosis of patients with hepatitis b virus-related hepatocellular carcinoma based on propensity score matching analysis. Cancer Manag Res. 2022;14:2193–2202. https://doi.org/10.2147/CMAR.S368366

Article  PubMed  PubMed Central  Google Scholar 

Jiang D, Chen C, Liu X, et al. Concurrence and impact of hepatic steatosis on chronic hepatitis B patients: a systematic review and meta-analysis. Ann Transl Med. 2021;9(23):1718–1718. https://doi.org/10.21037/ATM-21-3052

Article  PubMed  PubMed Central  Google Scholar 

van Kleef LA, Choi HSJ, Brouwer WP, et al. Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B. JHEP Rep. 2021. https://doi.org/10.1016/J.JHEPR.2021.100350

Article  PubMed  PubMed Central  Google Scholar 

Reggidori N, Bucci L, Santi V, Stefanini B, Lani L, Rampoldi D, Ghittoni G, Farinati F, Masotto A, Stefanini B, Mega A, Biasini E, Foschi FG, Svegliati-Baroni G, Sangiovanni A, Campani C, Raimondo G, Vidili G, Gasbarrini A, Celsa C, Di Marco M, Giannini EG, Sacco R, Brunetto MR, Azzaroli F, Magalotti D, Morisco F, Rapaccini GL, Nardone G, Vitale A, Trevisani F; Italian Liver Cancer (ITA.LI.CA) group. Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs. JHEP Rep. 2023 May 5;5(8):100784. https://doi.org/10.1016/j.jhepr.2023.100784. PMID: 37520672; PMCID: PMC10382941.

Chen VL, Yeh ML, Yang JD, et al. Effects of cirrhosis and diagnosis scenario in metabolic-associated fatty liver disease-related hepatocellular carcinoma. Hepatol Commun. 2021;5(1):122–132. https://doi.org/10.1002/HEP4.1606

Article  PubMed  Google Scholar 

Loomba R, Yang HI, Su J, et al. Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study. Am J Epidemiol. 2013;177(4):333–342. https://doi.org/10.1093/AJE/KWS252

Article  PubMed  PubMed Central  Google Scholar 

Nair S, Mason A, Eason J, Loss G, Perrillo RP. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? Hepatology. 2002;36(1):150–155. https://doi.org/10.1053/jhep.2002.33713

Article  PubMed  Google Scholar 

N’Kontchou G, Paries J, Htar MTT, et al. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis. Clin Gastroenterol Hepatol. 2006;4(8):1062–1068. https://doi.org/10.1016/J.CGH.2006.05.013

Article  PubMed  Google Scholar 

Ascha MS, Hanouneh IA, Lopez R, Tamimi TAR, Feldstein AF, Zein NN. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology. 2010;51(6):1972–1978. https://doi.org/10.1002/HEP.23527

Article  PubMed  Google Scholar 

Ochiai Y, Kawamura Y, Kobayashi M, et al. Effects of alcohol consumption on multiple hepatocarcinogenesis in patients with fatty liver disease. Hepatol Res. 2021;51(1):62–68. https://doi.org/10.1111/HEPR.13572

Article  CAS  PubMed  Google Scholar 

Simon TG, King LY, Chong DQ, et al. Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies. Hepatology. 2018;67(5):1797–1806. https://doi.org/10.1002/HEP.29660

Article